Know Labs appoints CFO Peter Conley and CPO Steven Kent to lead toward FDA clearance

USBC, Inc.

Peter Conley appointed CFO and SVP Intellectual Property, with 34 years finance and IP experience.
Steven Kent appointed Chief Product Officer, responsible for product development and clinical testing.
Company progresses toward FDA clearance for non-invasive glucose monitor; executive team expanded.
Leo Trautwein remains CMO; Masanori King Takee as SVP Software Engineering.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Peter Conley

Chief Financial Officer and SVP Intellectual Property

USBC · USBC, Inc.

Effective: 2022-05-24
Filed: May 31, 2022, 7:59 PM ET

Peter Conley, Chief Financial Officer and SVP Intellectual Property (IP) – Mr. Conley brings over 34 years of corporate finance and equity capital markets experience, more than $5B in equity transactions, and over 20 years of specialization in strategic IP analysis, IP development and IP monetization to Know Labs, joining the company as Chief Financial Officer and SVP, Intellectual Property.

Appointed

Steven Kent

Chief Product Officer

USBC · USBC, Inc.

Effective: 2022-05-24
Filed: May 31, 2022, 7:59 PM ET

Steven Kent, Chief Product Officer – Mr. Kent joins Know Labs as Chief Product Officer, where he will be responsible for product development and clinical testing.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Conley was appointed as Chief Financial Officer and SVP Intellectual Property at USBC, Inc..

Action: appointed
Role: Chief Financial Officer and SVP Intellectual Property

Exact text from the filing

Peter Conley, Chief Financial Officer and SVP Intellectual Property (IP) – Mr. Conley brings over 34 years of corporate finance and equity capital markets experience, more than $5B in equity transactions, and over 20 years of specialization in strategic IP analysis, IP development and IP monetization to Know Labs, joining the company as Chief Financial Officer and SVP, Intellectual Property.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Kent was appointed as Chief Product Officer at USBC, Inc..

Action: appointed
Role: Chief Product Officer

Exact text from the filing

Steven Kent, Chief Product Officer – Mr. Kent joins Know Labs as Chief Product Officer, where he will be responsible for product development and clinical testing.

View on SEC.gov

USBC, Inc. filing history →

Source: SEC EDGAR

accession 0001161697-22-000276

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.